FOR ENTREPRENEURS/INVESTORS
Current
life style and dietary habits are fueling the increasing prevalence of specific
diseases, including diabetes, hypertension, non-alcoholic fatty liver disease /
non-alcoholic steatohepatitis (NAFLD/NASH), dyslipidemia and the metabolic
syndrome, that require targeted therapies not always available and/or a
multidisciplinary approach difficult to standardize. Our team has the necessary
expertise to advice companies and investors on the best, potential strategies
to focus on and the most promising R&D programs worth investing.